Answers are grounded in this paper and cite their sources.
This research analyzes the therapeutic potential of 4-bromophenyl chalcones derived from condensation reactions, highlighting their effectiveness as enzyme inhibitors.
Nine substituted styryl 4-bromophenyl ketones were synthesized by potassium hydrogen phthalate (KHC 6 H 4 O 4 ) assisted crossed-aldol condensation of 4-bromoacetophenone and benzaldehydes in stirring method. This method yields more than 80 % product. In this condensation, the effect of solvents was studied. The purities of these enones were analyzed by their data reported earlier in literature. The molecular structure of 4-bromophenyl chalcones was investigated using Density Functional Theory (DFT) at the B3LYP/6-311G(d,p) level of theory. The simulations provide insights into total energy, frontier molecular orbitals (HOMO and LUMO), and molecular electrostatic potential (MEP) surfaces. Molecular docking analysis of 4-bromophenyl chalcones against D-glutamate ligase (PDB ID:1UAG) bacterial protein that gives highest binding affinity value -6.63 with the compound 1c. ADMET results support the further development of pharmacologically active drugs. The enzyme target prediction ligand-based method demonstrates 4-bromophenyl chalcone derivatives ( 1a-i ) effective inhibitors of oxidoreductase, kinases, and proteases enzymes. These findings revealed 4-bromophenyl chalcone derivatives as potential candidates for therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Sudha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: